Brief: Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results And Provides Business Update
Nov 13 (Reuters) - Allena Pharmaceuticals Inc ALNA.O :
* ALLENA PHARMACEUTICALS REPORTS THIRD QUARTER 2019
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q3 LOSS PER SHARE $0.57
* Q3 EARNINGS PER SHARE ESTIMATE $-0.49 -- REFINITIV IBES
DATA
* AS OF SEPTEMBER 30, 2019, CASH AND CASH EQUIVALENTS WERE
$39.4
MILLION, AS COMPARED TO $61.6 MILLION AS OF DECEMBER 31, 2018
Source text for Eikon: ID:nGNX2SzWMm
Further company coverage: ALNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allena Pharmaceuticals
See all newsBrief: Allena Pharmaceuticals Inc - On September 6, Received Notice From Nasdaq That Its Shares Will Be Suspended At Open Of Business On September 8, 2022
U.S. STOCKS ON THE MOVE-Relmada, Entera Bio, Eli Lilly
U.S. STOCKS ON THE MOVE-ChannelAdvisor, HyreCar, ADT, miners
U.S. STOCKS ON THE MOVE-Timken, Bed Bath & Beyond, HyreCar, chip stocks
Allena down on bankruptcy filing